| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008888 | Annals of Allergy, Asthma & Immunology | 2005 | 5 Pages |
Abstract
These findings suggest that high doses of montelukast modulate the production of IL-6, TNF-α, and MCP-1 through the inhibition of NF-κB activation. However, the anti-inflammatory effect of montelukast at therapeutic doses in patients with asthma needs to be further investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Shinji MD, Takashi MD, Yoshiko PhD, Haruyuki MD, Tomoyo MD, Susumu MD,